NorthWest Biotherapeutics Inc (NWBO)

[skitahoe]

When the data was first displayed at NYAS I noted that something didn't add up to me, the K-M curves didn't add up to over 50 being alive at 5 years or longer. Without that it would be impossible for the Top 100 to have a median of over 5 years.

I believe it was Meirluc who explained why, namely that not every patient was accounted for in the curves. The patients who started the trial on the placebo but crossed over to DCVax-L were apparently not included. I don't know if this was an intentional effort to increase attention when the Journal is finally issued, but I do believe that the Journal will show that nearer 25% or more survived at 5 years when all patients are taken into consideration. It is either that or both Dr. Liau and Ashkan exaggerating when they discussed Top 100 data and I'm quit e confident that both know how to do the math properly.

Let's get the full story in the Journal and the full TLD Statement from the company, then perhaps we'll know far more about what we're talking about. Let's also learn how close we are to regulatory submissions, or even approvals, we may just be very surprised.

Gary